H1N1 Virus (Swine Flu)

FDA Approves Seasonal Influenza Vaccine Fluarix for Pediatric Use

Washington, D.C.–(ENEWSPF)–October 19, 2009.  The U.S. Food and Drug Administration today approved use of the seasonal influenza vaccine Fluarix for children ages 3 years to 17 years. Previously, this vaccine, which contains inactivated (killed) influenza A and B viruses, had been approved for use in adults, ages 18 years and older.

Proud member of LION Publishers

Most read stories this week

Take a Survey

ARCHIVES